Vijaya V Bapat, MD in Cary, NC - Pediatrics

Vijaya V Bapat, MD is a Pediatrics physician based in Cary, North Carolina. Vijaya V Bapat is licensed to practice in North Carolina (license number 58391) and her current practice location is 227 Beckingham Loop, Cary, North Carolina. She can be reached at her office (for appointments etc.) via phone at (919) 319-7294.

NPI number for Vijaya V Bapat is 1033449731 and her current mailing address is 227 Beckingham Loop, Cary, North Carolina. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1033449731.

Contact Information

	Vijaya V Bapat, MD
	227 Beckingham Loop, Cary, NC 27519-6374
	(919) 319-7294
	Not Available

Physician's Profile

Full Name	Vijaya V Bapat
Gender	Female
Speciality	Pediatrics
Location	227 Beckingham Loop, Cary, North Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1033449731
Provider Enumeration Date: 01/04/2010
Last Update Date: 01/04/2010

Medical Identifiers

Medical identifiers for Vijaya V Bapat such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1033449731	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	58391 (North Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Vijaya V Bapat is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Vijaya V Bapat, MD 227 Beckingham Loop, Cary, NC 27519-6374 Ph: (919) 319-7294	Vijaya V Bapat, MD 227 Beckingham Loop, Cary, NC 27519-6374 Ph: (919) 319-7294

News Archive

Average age of first drug use among teens is rising, study shows

The average age at which teens and young adults start using drugs has been rising, according to a study published today in JAMA Pediatrics.

EU gives 32 million Euro for vaccines to stop tuberculosis

The European Commission today launched the largest-ever collaborative tuberculosis (TB) initiative for World TB-day, March 24. Fifty-two research teams from academia and industry from 15 European and African countries are joining forces with the European Commission to help eradicate TB. Globally, TB kills 2 million people a year, with one-third of the world's population currently infected with the bacillus, Mycobacterium tuberculosis (Mtb). While most cases and deaths occur in developing countries, resistant Mtb strains are mainly found among the poorest people in developed countries, as incomplete treatment increases drug resistance. The European Union is confronting the re-emerging threat of TB by investing €32 million in two overlapping research projects. This cash will be used in an accelerated effort to develop new, effective vaccines to fight TB.

New low-cost combined therapy shows promise against malaria

Malaria brings misery and death to millions in the developing world each year, and fighting it keeps medical researchers up at night because the mosquito-borne parasite Plasmodium falciparum, which causes the deadliest form of the disease, has developed resistance to every drug thrown at it. Resistance has cut short the useful life of nearly every therapy tried so far, experts say.

Study explores how human ACE2 variants can modify SARS-CoV-2 binding

A recent tour-de-force study by researchers from the United Kingdom reveals variants of the human angiotensin-converting enzyme 2 (ACE2) that can improve or decrease binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – including two variants with distinct population distributions showing an enhanced affinity for viral spike glycoprotein.

Scil Technology receives public research grant for novel rheumatoid arthritis treatments

Scil Technology GmbH, a biopharmaceutical company with core expertise in protein drug development, formulation and analytics, today announced that it has been awarded research funding by the German Federal Ministry of Education and Research (BMBF) under BMBF's KMU-innovativ scheme. The EUR 0.9 million grant supports Scil Technology's research program to explore the therapeutic potential of repellent proteins for the treatment of rheumatoid arthritis (RA).

Pediatrics Doctors in Cary, NC

Dr. Hugh M Powell Jr., MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1001 Crescent Grn, Cary, NC 27518 Phone: 919-467-1057 Fax: 919-461-8179
David Thomas Outlaw, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 224 High House Rd, Ste 100, Cary, NC 27513 Phone: 919-380-7531 Fax: 919-380-0686
Dr. Renee H Johnson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1001 Crescent Green, Cary, NC 27511 Phone: 919-467-3211 Fax: 919-467-5315
Dr. Anil Kumar Kasula, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 155 Parkway Office Ct, Ste 100, Cary, NC 27518 Phone: 919-852-3456 Fax: 919-852-0911
Dr. Jennifer Alys Durand-smith, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1001 Crescent Grn, Cary, NC 27518 Phone: 919-467-3211 Fax: 919-461-8179
Thomas F Flaherty, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1515 Sw Cary Pkwy, Suite 220, Cary, NC 27511 Phone: 919-387-3160 Fax: 919-387-3165

Vijaya V Bapat, MD - Pediatrics in Cary, NC